Scienture Holdings, Inc.
Pharmaceutical company · Commack, New York, United States · Nasdaq: SCNX
Scienture Holdings, Inc. is a pharmaceutical company headquartered in Commack, New York, United States. Its shares trade on Nasdaq under the ticker SCNX. It has reported private securities offerings to the US SEC, most recently $1.7 million sold in a notice filed in 2025.
Scienture Holdings at a glance
What does Scienture Holdings do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $1.7 million sold (2025).
Frequently asked questions about Scienture Holdings
Where is Scienture Holdings headquartered?
Scienture Holdings, Inc. is headquartered in Commack, New York, United States.
What does Scienture Holdings do?
Scienture Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Scienture Holdings a public company?
Yes. Scienture Holdings, Inc. trades on Nasdaq under the ticker SCNX.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences